When was Stereotaxis founded?

Stereotaxis was founded in 1990 and raised its 1st funding round 8 years after it was founded.

Where is Stereotaxis located?

Stereotaxis is headquartered in St. Louis, United States. It is registered at St. Louis.

Who is the current CEO of Stereotaxis?

William C Mills of Stereotaxis.

How many employees does Stereotaxis have?

As of May 31, 2026, the latest employee count at Stereotaxis is 193.

Is Stereotaxis a funded company?

Stereotaxis is a funded company, having raised a total of $52M across 7 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Aug 02, 1998.

When was the latest funding round of Stereotaxis?

Stereotaxis' latest funding was a $***** Post IPO round on May 26, 2020, with participation from 1 investor.

What is the annual revenue of Stereotaxis?

Annual revenue of Stereotaxis is $32.4M as on Dec 31, 2025.

Where does Stereotaxis rank among its competitors?

Stereotaxis ranks 8th amongst 226 active competitors, of which 101 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was SS Innovations International, which secured $18.6M in Mar, 2026.

Who are the top competitors of Stereotaxis?

Stereotaxis' top competitors include Intuitive, Brainlab and Medical Microinstruments. Among them, SS Innovations International secured the most recent funding round in March, 2026.

Stereotaxis - 2026 Company Profile, Team, Funding, Competitors & Financials

Stereotaxis is a public company based in St. Louis (United States), founded in 1990. It operates as a Surgical robotics company advancing minimally invasive endovascular intervention for improved patient care. Stereotaxis has raised $52M in funding. The company has 226 active competitors, including 101 funded and 32 that have exited. Its top competitors include companies like Intuitive, Brainlab and Medical Microinstruments.

Company Details

Surgical robotics company advancing minimally invasive endovascular intervention for improved patient care. It pioneers and globally leads in surgical robotics for minimally invasive endovascular intervention. The mission centers on discovering, developing, and delivering robotic systems, instruments, and information solutions for the interventional laboratory. These innovations empower physicians to provide exceptional patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance productivity, connectivity, and intelligence in the operating room. They focus on robotic magnetic navigation, cardiac ablation, electrophysiology, and endovascular procedures. The company aims to revolutionize surgical practice through innovation and technology, improving outcomes for patients with heart rhythm disorders and other endovascular conditions.

Website: www.stereotaxis.com/
Social
Email ID: *****@stereotaxis.com
Registered Address: St. Louis

Key Metrics

Founded Year

1990

Location

St. Louis, United States

Stage

Public

Total Funding

$52M in 7 rounds

Latest Funding Round

Post IPO, May 26, 2020, $*****

Investors

Ascension Ventures & 9 more

Ranked

8^th among 226 active competitors

Annual Revenue

$32.4M as on Dec 31, 2025

Employee Count

193 as on May 31, 2026

Investment & Acquisitions

Robocath

Similar Companies

Intuitive & 269 more

Exit Details

Public

View Stereotaxis' full profile

Stereotaxis is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Stereotaxis, Inc CIN: 94-3120386 , Belgium, Active	Dec 31, 1989	-	130 (As on Dec 31, 2021)	-
Stereotaxis, Inc. CIN: 1289340 , United States, Active	Jun 12, 1990	$32.4M (As on Dec 31, 2025)	122 (As on Dec 31, 2023)	-

Stereotaxis got listed on Aug 12, 2004.

Click here to take a look at Stereotaxis's IPO in detail

Stereotaxis has raised a total funding of $52M over 7 rounds. Its first funding round was on Aug 02, 1998. Its latest funding round was a Post IPO round on May 26, 2020 for $*****. 1 investor participated in its latest round. Stereotaxis has 10 institutional investors.

Here is the list of recent funding rounds of Stereotaxis:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 26, 2020	4395945	Post IPO	2072378	7717126	5150475	7257242
Aug 20, 2019	5449743	Post IPO	7519226	7675958	9500367	5022078
Oct 04, 2016	3997115	Post IPO	9550565	3571584	5034798	5742322

Access funding benchmarks and valuations. Sign up today!

View details of Stereotaxis's funding rounds and investors

Stereotaxis' employee count trend

Stereotaxis has 193 employees as of May 26. Here is Stereotaxis's employee count trend over the years:

Uncover Stereotaxis' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Stereotaxis include Intuitive, Brainlab and Medical Microinstruments. Here is the list of Top 10 competitors of Stereotaxis, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Intuitive 1995, Sunnyvale (United States), Public	Developer of robotic-assisted surgical systems	$17M	Gershon Capital, ELM Responsible Investments ... & 11 others	81/100
2nd	Brainlab 1989, Munich (Germany), Series B	Software and integrated solutions for surgical and radiotherapy applications	$12.7M	EMH Partners, Intel Capital & 3 others	75/100
3rd	Medical Microinstruments 2015, Calci (Italy), Series C	Provider of robotic platform using micro instruments for surgery	$210M	Fidelity Investments, Deerfield & 11 others	70/100
4th	PROCEPT BioRobotics 2009, Redwood City (United States), Public	Developer of a therapeutic device for benign prostatic hyperplasia	$349M	Fidelity Investments, Viking Global Investors ... & 5 others	70/100
5th	Vicarious Surgical 2014, Boston (United States), Public	Provider of VR-based surgical robotic system for physicians	$43.2M	Khosla Ventures, Rothenberg Ventures & 17 others	67/100
6th	Robocath 2009, Rouen (France), Acquired	Developer of robotic solutions to treat cardiovascular diseases	$57.9M	M Capital, GO CAPITAL & 18 others	66/100
7th	eCential Robotics 2009, Gieres (France), Series C	Developer of robotic surgery platform combining imaging, navigation, and robotic assistance	$134M	Bpifrance, Caisse D Epargne & 7 others	66/100
8th	Stereotaxis 1990, St. Louis (United States), Public	Surgical robotics company advancing minimally invasive endovascular intervention for improved patient care	$52M	Ascension Ventures, Ampersand Capital & 8 others	64/100
9th	ForSight Robotics 2020, Yokneam Illit (Israel), Series B	Provider of an AI-based ophthalmic surgical robot for healthcare professionals	$195M	Eclipse, Mithril & 6 others	64/100
10th	SS Innovations International 2015, Gurugram (India), Seed	Developer of healthcare professional robots	$2.45M	Yijing Capital, ZSVC & 4 others	63/100